Truqap can be a kinase inhibitor that actually works by blocking pathways that enable the cancer cells survive and develop, so lowers cancer growth. Truqap is from a category of medicines named an AKT inhibitor. Truqap been given FDA acceptance on November seventeen, 2023, after good final results in the https://cordelli222nzi4.dailyblogzz.com/profile